News

In recent weeks, Boston Scientific has faced multiple voluntary global recalls of its Suture Cinch endoscopic devices and ENROUTE Transcarotid Neuroprotection systems, alongside a cybersecurity incident that disrupted operations and led to reduced full‑year 2026 sales and earnings guidance. These simultaneous product quality issues, operational disruptions, and softer demand for key franchises raise fresh questions about the resilience of Boston Scientific’s previously growth-focused...

Boston Scientific (BSX) is back in focus after a series of voluntary global recalls affecting its ENROUTE Transcarotid Neuroprotection Systems and OverStitch Suture Cinch devices, along with a separate cybersecurity incident that has disrupted operations and lowered 2026 guidance. Against this backdrop of recalls and a cybersecurity disruption, Boston Scientific’s recent share price performance has weakened. The stock is at US$48.37 with a year-to-date share price decline of 48.93%, alongside...

Apple faces a £2 billion ($2.7 billion) lawsuit brought by UK app developers who accused Thursday the US tech giant of giving its own advertising services an unfair advantage by imposing tougher privacy rules on third parties.The claimants argue that the system was "designed and implemented unfairly and without proper consultation, imposing stricter requirements on third-party app developers than on its own services."

Boston Scientific (NYSE: BSX) has initiated multiple worldwide product recalls, including a Class I recall of its ENROUTE Transcarotid Neuroprotection System due to risks of arterial sheath tip separation. The company has also begun Class II recalls of certain OverStitch Suture Cinch endoscopic devices, citing deployment and suture cutting failures. These recalls affect widely distributed products and introduce added operational, regulatory and reputational pressures for Boston Scientific in...

Costco Wholesale (NasdaqGS:COST) has been asked by the US Department of Justice for detailed records as part of an expanded antitrust investigation into beef pricing. The broadened probe now covers major food retailers, with authorities seeking information on pricing practices and supply chain arrangements for beef products. The inquiry raises potential regulatory and operational questions for Costco as a key buyer and seller of beef in the US grocery market. Consider reviewing other...

F recalls nearly 149K Mustang vehicles over an electrical wiring defect that could cause loss of drive power or disrupt key functions.

A collective action filed at London's Competition Appeal Tribunal accuses Apple of imposing stricter tracking rules on third-party developers than on its own services

Recent developments in the e-commerce sector highlight challenges facing companies like Alibaba Group Holding Limited. The company is under scrutiny due to allegations of false and misleading statements about its affiliations and operational risks, leading to a class action lawsuit filed against it. Accusations include affiliations with the Chinese Ministry of Industry and Information Technology and unauthorized access to AI models, which has impacted its stock price. This legal dispute...

Investing.com -- Apple Inc is facing a £2 billion ($2.7 billion) lawsuit in London brought on behalf of app developers over its app tracking rules. The iPhone maker is accused of abusing its power to impose stricter restrictions on third parties than on its own services.

Apple (NASDAQ:AAPL) is facing a £2 billion ($2. 7 billion) lawsuit in London brought on behalf of app developers over its App Tracking Transparency rules, with the claim alleging that the company imposed stricter requirements on third-party developers than on its own services.

Meta Platforms will pay up to $18 billion and significantly overhaul its teen-usage policies across its platforms.

While Space Exploration Technologies Corp. is one of the biggest enterprises in the world today, this was not always the case, as CEO Elon Musk shared how repeated initial launch failures cast uncertainty over the future of the commercial spaceflight...

LONDON, Sept 3 (Reuters) - Apple is facing a £2 billion ($2.7 billion) London lawsuit brought on behalf of app developers over its app tracking rules, with the iPhone maker accused of abusing its

Alphabet stock soared the last time a judge rejected the Justice Department's bid to force it to sell part of its business.

Ford Motor Company (NYSE:F) is recalling 148,663 Mustang vehicles in the US from the 2024 to 2026 model years because engine-compartment wiring harness ground connections could fracture. The defect can potentially cause a loss of drive power and disable functions such as the headlights, windshield washer system, air conditioning, and engine cooling fan, increasing the […]

Wix.com Ltd. previously announced a collaboration with Google to embed its Wix Harmony website creation tools directly inside Gemini as a connected app, allowing users to build, manage, and analyze full-featured sites through natural-language interactions without leaving the Gemini interface. At the same time, multiple securities class action filings now question prior disclosures about the competitiveness and cost profile of Wix’s AI products, putting added scrutiny on how initiatives like...

The US Justice Department expanded its antitrust inquiry of the meatpacking industry by demanding information on surging beef prices from eight major food retailers, including Amazon.com Inc., Costco Wholesale Corp. and Walmart Inc.

Google avoids a forced divestiture of its advertising exchange despite an earlier ruling that it illegally monopolized key ad-tech markets.

Apple (NasdaqGS:AAPL) has filed a lawsuit against OpenAI and a former engineer over alleged theft of confidential circuit schematics and related trade secrets. The complaint accuses the former Apple employee of misappropriating proprietary hardware designs and integrating them into OpenAI projects. Apple is seeking damages, a preliminary injunction, and court orders to destroy any materials that allegedly contain its protected technology. The case adds fresh scrutiny to how major AI players...

Citi said continued advertiser spending and accelerating AI demand at AWS support its bullish view of Amazon.

Tesla's (TSLA) internal engineering platforms may be accessed by an independent expert after an Aust

While Space Exploration Technologies Corp. (NASDAQ:SPCX) is one of the biggest enterprises in the world today, this was not always the case, as CEO Elon Musk shared how repeated initial launch failures cast uncertainty over the future of the commercial spaceflight company. Peter Diamandis Recalls SpaceX’s Failures In a post on X on Sunday, X Prize Foundation‘s Executive Chairman Peter Diamandis shared how everyone knows the “trillion-dollar version of SpaceX,” but nobody remembered that “Elon’s

Amazon is facing a new lawsuit from the FTC and 22 states for allegedly secretly charging businesses more for advertising.

The Justice Department once threatened Walmart's pharmacies with billions in civil penalties over opioid prescriptions. What prosecutors actually walked away with tells a very different story about who held the leverage.

The FTC plans to file a lawsuit against Amazon that will allege the company manipulated prices businesses paid to advertise on its retail platform.

AMZN stock dropped on Monday after a Wall Street Journal report said the FTC plans to sue the company over how it prices ads on its retail site.

Key takeawaysThe FTC and more than 20 state attorneys general reportedly plan to sue Amazon over its advertising-auction practices. Regulators are expected to allege that undisclosed price floors increased advertisers’ costs and generated tens of billions of dollars for Amazon.

Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as MIMRYLO, for the treatment of erythrocytosis in adults with polycythemia vera, or PV. The approval marks the company’s second FDA-approved medicine this year, following the M

Eli Lilly stock has delivered very strong gains over the past five years. Current checks give a mixed read on valuation, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside, while market based multiples look closer to fair. Eli Lilly has returned 373.6% over five years, which puts a lot of optimism into the share price and raises the bar for what counts as good value today. The expanded use of drugs like Mounjaro and Zepbound in metabolic and cardiovascular care...

The fix already exists, but not every owner has it yet.